Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl− channel activation

AUTOR(ES)

Vaandrager, Arie. B.

FONTE

The National Academy of Sciences

RESUMO

A recently cloned isoform of cGMP-dependent protein kinase (cGK), designated type II, was implicated as the mediator of cGMP-provoked intestinal Cl− secretion based on its localization in the apical membrane of enterocytes and on its capacity to activate cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channels. In contrast, the soluble type I cGK was unable to activate CFTR in intact cells, although both cGK I and cGK II could phosphorylate CFTR in vitro. To investigate the molecular basis for the cGK II isotype specificity of CFTR channel gating, we expressed cGK II or cGK I mutants possessing different membrane binding properties by using adenoviral vectors in a CFTR-transfected intestinal cell line, and we examined the ability of cGMP to phosphorylate and activate the Cl− channel. Mutation of the cGK II N-terminal myristoylation site (Gly2 → Ala) reduced cGK II membrane binding and severely impaired cGK II activation of CFTR. Conversely, a chimeric protein, in which the N-terminal membrane-anchoring domain of cGK II was fused to the N terminus of cGK Iβ, acquired the ability to associate with the membrane and activate the CFTR Cl− channel. The potency order of cGK constructs for activation of CFTR (cGK II > membrane-bound cGK I chimer ≫ nonmyristoylated cGK II > cGK Iβ) correlated with the extent of 32P incorporation into CFTR observed in parallel measurements. These results strongly support the concept that membrane targeting of cGK is a major determinant of CFTR Cl− channel activation in intact cells.

Documentos Relacionados

• Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator.
• Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase
• Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.
• Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl- channels.
• Type II cGMP-dependent Protein Kinase Mediates Osteoblast Mechanotransduction*S⃞